Global shares have suddenly rebounded since the pricing panic in April sent markets at low fresh, by rewarding the dip buyers who intervened and seized the moment.
Now, while the market moves on the side just below the peaks of all time, those who have missed April’s rebound poses the obvious question: when will the next dive purchase opportunity arise?
But here is the truth: hoping for another panic is not a strategy. A more intelligent decision is to stay in advance by targeting the undervalued actions that the market may have misused. Overold, fundamentally healthy companies are often hiding in sight – if you know where to look.
This is where the owner of Investing.com Fair value The tool can prove a game changer.
By applying up to 17 fundamental models of quality investment, it provides a Calculation of prices in real time for each stock on the market, which makes pricing simple and quick to identify the market.
Many investors have already used these signals to discover hidden gems during market slowdowns – the market blows had neglected, but fair value was reported early.
Take Banco Santander (BME 🙂 and Gilead Sciences (Nasdaq :), for example. The two were identified as undervalued by the fair value tool and have not only struck their projected advantage – they exceeded it.
You will find below how their stories took place:
1. Banco Santander: Deep Discing attracts buyers of declines, the stock goes up to Couier 67%
Systematic evaluation frameworks become particularly useful when the markets distribute fundamentally healthy companies. Banco Santander in April 2024 is a good example.
At the time, Santander was negotiated at only $ 4.79 per share despite a solid financial report – $ 49.65 billion in income and profits per share (BPA) of $ 0.73. This gap has placed the stock well below its estimated intrinsic value.
The InvestingPro InvestingPro value model, which relies on up to 17 institutional quality evaluation methods and explains factors such as market positioning, reported a 35% increase potential.
In the following 11 months, the stock increased regularly to $ 6.89, exceeding the initial projection with a gain of 49%.
While the fundamentals continued to improve – returned …
..